ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laviolette, M
Right arrow Articles by Boulet, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laviolette, M
Right arrow Articles by Boulet, L.
Eur Respir J 1995; 8: 1465-1472
Copyright © ERS Journals Ltd 1995

Original Articles

Blood eosinophil leukotriene C4 production in asthma of different severities

M Laviolette, C Ferland, JF Comtois, K Champagne, M Bosse, and LP Boulet

In asthma, activation and recruitment of eosinophils to the bronchial mucosa amplifies many cellular functions. The blood eosinophil count and the number of hypodense eosinophils increase with asthma severity. Eosinophils produce numerous proinflammatory mediators in response to a variety of agonists, notably the peptido-leukotriene (LT) C4, a potent bronchoconstrictor. In this study, we have evaluated blood eosinophil LTC4 release and its modulation by cytokines in normal individuals and in subjects with asthma of various severities: mild (beta 2-agonist on demand); moderate (inhaled steroids on a regular basis); and severe (inhaled and oral steroids on a regular basis). Eosinophils were isolated using a modified Percoll gradient technique, which recovers both hypodense and normodense eosinophils in a global cell population. Eosinophils released detectable amounts of LTC4 only in the presence of the stimulus (calcium ionophore A23187, 2 microM). The ionophore-induced LTC4 release was greater in moderate asthmatics (mean +/- SEM 5.7 +/- 1.3 pg x 10(3)/250,000 eosinophils) than in normal individuals (1.6 +/- 0.4 pg x 10(3)/250,000 eosinophils), mild asthmatics (1.8 +/- 0.3 pg x 10(3)/250,000 eosinophils) and severe asthmatics (2.0 +/- 0.3 pg x 10(3)/250,000 eosinophils). Granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin-5 (IL-5) amplified the ionophore-induced LTC4 release in the four groups from 1.9 to 2.6 and 1.9 to 2.8 fold, respectively. Interleukin-3 (IL-3) did not increase LTC4 production except by the eosinophils of the severe asthmatics whose ionophore-induced LTC4 production was enhanced by 1.9 fold. These data demonstrate that the asthmatic bronchial inflammatory process may modify blood eosinophil LTC4 release and its modulation by cytokines according to asthma severity and treatment.


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Feltenmark, N. Gautam, A. Brunnstrom, W. Griffiths, L. Backman, C. Edenius, L. Lindbom, M. Bjorkholm, and H.-E. Claesson
Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells
PNAS, January 15, 2008; 105(2): 680 - 685.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
B. Sitkauskiene, A.-K. Johansson, S. Sergejeva, S. Lundin, M. Sjostrand, and J. Lotvall
Regulation of Bone Marrow and Airway CD34+ Eosinophils by Interleukin-5
Am. J. Respir. Cell Mol. Biol., March 1, 2004; 30(3): 367 - 378.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
Z. Csoma, S. A. Kharitonov, B. Balint, A. Bush, N. M. Wilson, and P. J. Barnes
Increased Leukotrienes in Exhaled Breath Condensate in Childhood Asthma
Am. J. Respir. Crit. Care Med., November 15, 2002; 166(10): 1345 - 1349.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Thivierge, M. Doty, J. Johnson, J. Stankova, and M. Rola-Pleszczynski
IL-5 Up-Regulates Cysteinyl Leukotriene 1 Receptor Expression in HL-60 Cells Differentiated into Eosinophils
J. Immunol., November 1, 2000; 165(9): 5221 - 5226.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. T. HOLGATE and A. P. SAMPSON
Antileukotriene Therapy . Future Directions
Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S147 - 153.
[Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
M. Guilbert, C. Ferland, M. Bossé, N. Flamand, S. Lavigne, and M. Laviolette
5-Oxo-6,8,11,14-Eicosatetraenoic Acid Induces Important Eosinophil Transmigration through Basement Membrane Components . Comparison of Normal and Asthmatic Eosinophils
Am. J. Respir. Cell Mol. Biol., July 1, 1999; 21(1): 97 - 104.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
A. S. Cowburn, S. T. Holgate, and A. P. Sampson
IL-5 Increases Expression of 5-Lipoxygenase-Activating Protein and Translocates 5-Lipoxygenase to the Nucleus in Human Blood Eosinophils
J. Immunol., July 1, 1999; 163(1): 456 - 465.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. SANO, N. M. MUÑOZ, H. SANO, J. CHOI, X. ZHU, B. JACOBS, and A. R. LEFF
Inhibition of cPLA2 Translocation and Leukotriene C4 Secretion by Fluticasone Propionate in Exogenously Activated Human Eosinophils
Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1903 - 1909.
[Abstract] [Full Text]

Home page
 Pharmacol. Rev.Home page
M. A. Giembycz and M. A. Lindsay
Pharmacology of the Eosinophil
Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the European Respiratory Society.